Show
Sort by
-
Migration of surrogate contaminants from paperboard to foods : effect of food and surrogate properties
-
- Journal Article
- A1
- open access
A recycler’s perspective on the implications of REACH and food contact material (FCM) regulations for the mechanical recycling of FCM plastics
-
Modelling and validation of the antifungal activity of DL-3-phenyllactic acid and acetic acid on bread spoilage moulds
-
Effect of storage temperature, water activity, oxygen headspace concentration and pasteurization intensity on the time to growth of Aspergillus fischerianus (teleomorph Neosartorya fischeri)
-
Pharmacokinetics in patients with cystic fibrosis : a systematic review of data published between 1999 and 2019
-
Validation of in-vitro antifungal activity of the fermentation quotient on bread spoilage moulds through growth/no-growth modelling and bread baking trials
-
An integrated paediatric population PK/PD analysis of dDAVP : how do PK differences translate to clinical outcomes?
-
Desmopressin oral lyophilisate in young children : new insights in pharmacokinetics and pharmacodynamics
-
- Journal Article
- A1
- open access
Pediatric pharmacology of desmopressin in children with enuresis : a comprehensive review
-
PKPD modeling and dosing considerations in advanced ovarian cancer patients treated with cisplatin-based intraoperative intraperitoneal chemotherapy
-
PBPK and its virtual populations : the impact of physiology on pediatric pharmacokinetic predictions of tramadol
-
A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers
-
Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.
-
Growth/no-growth models of in-vitro growth of Penicillium paneum as a function of thyme essential oil, pH, a, temperature
-
SAFEPEDRUG : safer pediatric drugs for children: what have we learned?
-
- Journal Article
- A1
- open access
Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer
-
Effect of packaging oxygen transmission rate on the shelf life of ready-to-heat foods susceptible to postcontamination during refrigerated and illuminated storage
-
A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients
-
The use of PBPK modeling across the pediatric age range using propofol as a case
-
- Conference Paper
- C3
- open access
Assessment of the antifungal preservation potential of natural water or oil soluble compounds in both in-vitro and bread baking trials
-
- Journal Article
- A1
- open access
A dried blood spot assay for paclitaxel and its metabolites
-
Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine
-
- Journal Article
- A1
- open access
Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
-
Claiming desmopressin therapeutic equivalence in children requires pediatric data : a population PKPD analysis
-
A model-based analysis of the kinetics of leukocytes in stage III ovarian cancer patients treated with neo-adjuvant chemotherapy, cytoreductive surgery and cisplatin-based intraperitoneal chemoperfusion
-
Solid fat influences sorbic acid partitioning and enhances the preservation effect on C. guilliermondii in biphasic food model systems
-
Population pharmacokinetic modeling of a desmopressin oral lyophilisate in growing piglets as a model for the pediatric population
-
Results of a multicenter population pharmacokinetic study of ciprofloxacin in children with complicated urinary tract infection
-
- Journal Article
- A1
- open access
A systems pharmacology model for inflammatory bowel disease
-
PK/PD studies in pigs leading to optimization of treatment dose in MNE?
-
- Conference Paper
- C3
- open access
A novel approach in paediatric drug research : the development of a juvenile pig model for pharmacokinetic/pharmacodynamic studies, using desmopressin as case 1
-
- Conference Paper
- C3
- open access
Pediatric drug development: towards maturity : desmopressin as a case
-
- Journal Article
- A1
- open access
Population pharmacokinetic modeling of a desmopressin oral lyophilisate in growing piglets as a model for the pediatric population
-
- Journal Article
- A1
- open access
Inactivation of Salmonella, Listeria monocytogenes and Escherichia coli O157:H7 inoculated on coriander by freeze-drying and supercritical CO2 drying
-
PBPK in preterm and term neonates : a review
-
- Conference Paper
- C3
- open access
Paediatric PBPK modelling of propofol using the middle out approach
-
Influence of pH and structure on sorbic acid distribution and growth of C. guilliermondii in fat-based products
-
- Journal Article
- A1
- open access
Pharmacokinetic analysis of modified-release metoprolol formulations : an interspecies comparison
-
Dosing and switching strategies for paliperidone palmitate 3-month formulation in patients with schizophrenia based on population pharmacokinetic modeling and simulation, and clinical trial data
-
Population pharmacokinetics of a novel once-every 3 months intramuscular formulation of paliperidone palmitate in patients with schizophrenia
-
Strategies for determining correct cytochrome P450 contributions in hepatic clearance predictions : in vitro-in vivo extrapolation as modelling approach and tramadol as proof-of concept compound
-
Modeling the relationship between exposure to abiraterone and prostate-specific antigen dynamics in patients with metastatic castration-resistant prostate cancer
-
- Journal Article
- A1
- open access
In vivo contribution of deoxynivalenol-3-β-D-glucoside to deoxynivalenol exposure in broiler chickens and pigs: oral bioavailability, hydrolysis and toxicokinetics
-
The influence of liquid oil, solid fat and pH on the inhibitory effect of potassium sorbate on Candida guilliermondii
-
Population pharmacokinetic modeling of tapentadol extended release (ER) in healthy subjects and patients with moderate or severe chronic pain
-
- Conference Paper
- C3
- open access
Bioequivalence in adults does not mean bioequivalence in children
-
Population pharmacokinetic modeling of canagliflozin in healthy volunteers and patients with type 2 diabetes mellitus
-
What about confidence intervals? : a word of caution when interpreting PTA simulations
-
Mycotoxin production and predictive modelling kinetics on the growth of Aspergillus flavus and Aspergillus parasiticus isolates in whole black peppercorns (Piper nigrum L)
-
Bioequivalence in adults is not always bioequivalence in children
-
A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU
-
- Journal Article
- A1
- open access
Effects of food and pharmaceutical formulation on desmopressin pharmacokinetics in children
-
Effect of food and pharmaceutical formulation on desmopressin pharmacokinetics in children
-
PK/PD modelling of the QT interval : a step towards defining the translational relationship between in vitro, awake Beagle dogs, and humans
-
Effect of food and pharmaceutical formulation on desmopressin pharmacokinetics in children
-
Deoxynivalenol-3-β-D-glucoside : in vitro cytotoxicity and in vivo oral bioavailability and hydrolysis in broiler chicken and pig
-
vRNA structured population model for Hepatitis C Virus dynamics
-
Strategies to increase the stability of intermediate moisture foods towards Zygosaccharomyces rouxii: the effect of temperature, ethanol, pH and water activity, with or without the influence of organic acids
-
Modelling of the growth/no growth interface of Wallemia sebi and Eurotium herbariorum as a function of pH, aW and ethanol concentration
-
Towards patient stratification in systemic lupus erythematosus using a systems pharmacology approach
-
Building an inflammatory bowel disease network, a systems pharmacology approach
-
Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities
-
Molecular properties determining unbound intracellular and extracellular brain exposure of CNS drug candidates
-
Oral bioavailability, hydrolysis, and comparative toxicokinetics of 3-acetyldeoxynivalenol and 15-acetyldeoxynivalenol in broiler chickens and pigs
-
Practical guidance for dosing and switching from paliperidone palmitate 1 monthly to 3 monthly formulation in schizophrenia
-
Correlation between prostate-specific antigen kinetics and overall survival in abiraterone acetate-treated castration-resistant prostate cancer patients
-
Physiologically based pharmacokinetic predictions of tramadol exposure throughout pediatric life: an analysis of the different clearance contributors with emphasis on CYP2D6 maturation
-
- Journal Article
- A1
- open access
Physiology-based IVIVE predictions of tramadol from in vitro metabolism data
-
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies
-
Population pharmacokinetic-pharmacodynamic (PKPD) modeling of ibrutinib in patients with B-cell malignancies
-
Packaging of fish and fishery products
-
Predictive modelling kinetics on the growth and mycotoxin production of Aspergillus flavus and Aspergillus parasiticus isolates in whole black peppercorns (Piper nigrum L.)
-
Effect of muscle, ageing time and modified atmosphere packaging conditions on the colour, oxidative and microbiological stability of packed beef
-
A model based analysis of IPEC dosing of paclitaxel in rats
-
Population pharmacokinetic analysis of abiraterone in chemotherapy-Na < ve and docetaxel-treated patients with metastatic castration-resistant prostate cancer
-
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach
-
Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery
-
Predictions of in vivo prolactin levels from in vitro Ki values of D-2 receptor antagonists using an agonist-antagonist interaction model
-
- Conference Paper
- C1
- open access
PredOxyPack®: how to predict the impact of the cold chain conditions on the oxygen barrier properties of packaging
-
Understanding and attitude regarding the shelf life labels and dates on pre-packed food products by Belgian consumers
-
Population pharmacokinetics of JNJ-37822681, a selective fast-dissociating dopamine D-2-receptor antagonist, in healthy subjects and subjects with schizophrenia and dose selection based on simulated D-2-receptor occupancy
-
Modelling and simulation of placebo effect: application to drug development in schizophrenia
-
New research on modified atmosphere packaging and pathogen behaviour
-
Development of a time-to-detect growth model for heat-treated Bacillus cereus spores
-
A quantitative microbiological exposure assessment model for Bacillus cereus in REPFEDs
-
Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries
-
Modeling continuous bounded outcome scores using beta regression with NONMEM (R) VII
-
Growth/no growth models for heat-treated psychrotrophic Bacillus cereus spores under cold storage
-
- Conference Paper
- C1
- open access
Predictive models to support manufacturers of processed meat in their compliance with EU regulation 2073/2005
-
Model based dosing rationale for darunavir when co-administered with low-dose ritonavir in pediatric HIV-1 infected patients
-
Heterogeneous photocatalysis of moxifloxacin: identification of degradation products and determination of residual antibacterial activity
-
Photocatalytic degradation of the antibiotic moxifloxacin: a deeper look at the degradation products and residual antibacterial activity
-
Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia
-
Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia, part I: the use of PANSS total score and clinical utility
-
Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia, part II: the use of subscales of the PANSS score
-
Population pharmacokinetic-pharmacodynamic modeling of haloperidol in patients with schizophrenia using positive and negative syndrome rating scale
-
Screening of different stress factors and development of growth/no growth models for Zygosaccharomyces rouxii in modified Sabouraud medium, mimicking intermediate moisture foods (IMF)
-
Shrinkage in nonlinear mixed-effects population models: quantification, influencing factors, and impact
-
Monitoring the intracellular pH of Zygosaccharomyces bailii by green fluorescent protein
-
A predictive model for the growth/no growth boundary of Zygosaccharomyces bailii at 7°C and conditions mimicking acidified sauces